| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.02 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.078 | 0.02 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.02 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.067 | 0.02 |
| mRNA | MS-275 | FIMM | pan-cancer | AAC | 0.29 | 0.02 |